홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

(1,1'-Binaphthalen)-2-yldi-tert-butylphosphine → 3-cyano-1-(2-methoxy-4-(trifluoromethyl)phenyl)-N-(thiazol-2-yl)isoquinoline-6-sulfonamide

HRID 1473449
인쇄

반응식

HRID 1473449 반응식
Cl[C:2]1[N:3]=[C:4]([C:30]2[CH:35]=[CH:34][C:33]([C:36]([F:39])([F:38])[F:37])=[CH:32][C:31]=2[O:40][CH3:41])[C:5]2[C:10]([CH:11]=1)=[CH:9][C:8]([S:12]([N:15](CC1C=CC(OC)=CC=1)[C:16]1[S:17][CH:18]=[CH:19][N:20]=1)(=[O:14])=[O:13])=[CH:7][CH:6]=2.[C:42]([Zn]C#N)#[N:43].C(P(C(C)(C)C)C1C=CC2C(=CC=CC=2)C=1C1C2C(=CC=CC=2)C=CC=1)(C)(C)C>FC(F)(F)C([O-])=O.[Pd+2].FC(F)(F)C([O-])=O.[Zn]>[C:42]([C:2]1[N:3]=[C:4]([C:30]2[CH:35]=[CH:34][C:33]([C:36]([F:38])([F:39])[F:37])=[CH:32][C:31]=2[O:40][CH3:41])[C:5]2[C:10]([CH:11]=1)=[CH:9][C:8]([S:12]([NH:15][C:16]1[S:17][CH:18]=[CH:19][N:20]=1)(=[O:14])=[O:13])=[CH:7][CH:6]=2)#[N:43]
참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 3

HCID 2734941(1,1'-Binaphthalen)-2-yldi-tert-butylphosphineHCID 866874313-chloro-1-(2-methoxy-4-(trifluoromethyl)phenyl)-N-(4-methoxybenzyl)-N-(thiazol-2-yl)isoquinoline-6-sulfonamideHCID 178514179HCID 178514179, 화합물

생성물 1

HCID 866874953-cyano-1-(2-methoxy-4-(trifluoromethyl)phenyl)-N-(thiazol-2-yl)isoquinoline-6-sulfonamide

시약·촉매·용매 2

HCID 23994
Zinc
촉매
HCID 2733347Palladium(II) trifluoroacetate촉매

반응 조건

온도
95 °C

실험 절차

A vial was charged with 3-chloro-1-(2-methoxy-4-(trifluoromethyl)phenyl)-N-(4-methoxybenzyl)-N-(thiazol-2-yl)isoquinoline-6-sulfonamide (Intermediate RRR) (59.39 mg, 0.096 mmol), dicyanozinc (22.49 mg, 0.192 mmol), racemic-2-di-t-butylphosphino-1,1′-binaphthyl (Strem Chemical, Newburyport, Mass.) (7.63 mg, 0.019 mmol), palladium(ii) trifluoroacetate (3.18 mg, 9.58 μmol), and zinc (3.13 mg, 0.048 mmol). The vial was flushed with Ar (g), then DMAC (479 μl) was added. The vial was sealed and heated in a 95° C. heating bath for 15 h. The mixture was diluted with water and extracted with EtOAc (4× via pipette). The combined organic extracts were combined and concentrated. The residue was taken up in DCM (1 mL) and TFA (0.5 mL). After 30 min, the mixture was diluted with MeOH, then concentrated. The residue was purified by chromatography on silica gel (12-g column, 0 to 6% MeOH/DCM). The resulting material was concentrated from DCM (3×), then taken up in DCM and filtered through a membrane filter. The collected solid was washed with DCM (2×), dried under a flow of N2 (g), then dried under vacuum to give 3-cyano-1-(2-methoxy-4-(trifluoromethyl)phenyl)-N-(thiazol-2-yl)isoquinoline-6-sulfonamide as an off-white solid: 1H NMR (400 MHz, DMSO-d6) δ ppm=12.99 (br. s., 1H), 8.95 (s, 1H), 8.70 (d, J=1.8 Hz, 1H), 8.07 (dd, J=1.9, 8.9 Hz, 1H), 7.83 (d, J=8.9 Hz, 1H), 7.63 (d, J=7.6 Hz, 1H), 7.57-7.50 (m, 2H), 7.31 (d, J=4.5 Hz, 1H), 6.91 (d, J=4.6 Hz, 1H), 3.76 (s, 3H); m/z (ESI) 491.2 (M+H)+.

후처리

  1. customThe vial was flushed with Ar (g)
  2. additionDMAC (479 μl) was added
  3. customThe vial was sealed
  4. temperatureheating bath for 15 h
  5. additionThe mixture was diluted with water
  6. extractionextracted with EtOAc (4× via pipette)
  7. concentrationconcentrated
  8. additionthe mixture was diluted with MeOH
  9. concentrationconcentrated
  10. customThe residue was purified by chromatography on silica gel (12-g column, 0 to 6% MeOH/DCM)
  11. concentrationThe resulting material was concentrated from DCM (3×)
  12. filtrationfiltered through a membrane
  13. filtrationfilter
  14. washThe collected solid was washed with DCM (2×)
  15. dry with materialdried under a flow of N2 (g)
  16. customdried under vacuum

출처 및 근거

ORD 기록
ord-015816a6de05496cb296725106b70477
출처 데이터셋
uspto-grants-2015_04
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09012443B2

반응 노트

이 페이지에서참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트